The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C viral infection in the United States

2002 ◽  
Vol 97 (3) ◽  
pp. 721-728 ◽  
Author(s):  
Miguel R. Arguedas ◽  
Gustavo R. Heudebert ◽  
Michael B. Fallon ◽  
Aaron A. Stinnett
Keyword(s):  
United States ◽  
Chronic Hepatitis ◽  
Cost Effectiveness ◽  
Hepatitis C ◽  
Viral Infection ◽  
Chronic Hepatitis C ◽  
Hepatitis A ◽  
The United States ◽  
The Cost

Cost-effectiveness of combination daclatasvir-sofosbuvir for treatment of genotype 3 chronic hepatitis C infection in the United States

2017 ◽  
Vol 20 (7) ◽  
pp. 692-702 ◽  
Author(s):  
Catherine Saint-Laurent Thibault ◽  
Divya Moorjaney ◽  
Michael L. Ganz ◽  
Bruce Sill ◽  
Shalini Hede ◽  
...  
Keyword(s):  
United States ◽  
Chronic Hepatitis ◽  
Cost Effectiveness ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
The United States ◽  
Hepatitis C Infection ◽  
Genotype 3

The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C

Hepatology ◽  
2000 ◽  
Vol 31 (4) ◽  
pp. 834-839 ◽  
Author(s):  
Robert P. Myers ◽  
James C. Gregor ◽  
Paul J. Marotta
Keyword(s):  
Chronic Hepatitis ◽  
Cost Effectiveness ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Hepatitis A ◽  
The Cost

scholarly journals Cost-effectiveness of Screening for Chronic Hepatitis C Infection in the United States

2013 ◽  
Vol 56 (10) ◽  
pp. 1382-1393 ◽  
Author(s):  
Mark H. Eckman ◽  
Andrew H. Talal ◽  
Stuart C. Gordon ◽  
Eugene Schiff ◽  
Kenneth E. Sherman
Keyword(s):  
United States ◽  
Chronic Hepatitis ◽  
Cost Effectiveness ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
The United States ◽  
Hepatitis C Infection

Reply: Cost-effectiveness of combination daclatasvir-sofosbuvir for treatment of genotype 3 chronic hepatitis C infection in the United States

2017 ◽  
Vol 20 (11) ◽  
pp. 1123-1125
Author(s):  
Catherine Saint-Laurent Thibault ◽  
Divya Moorjaney ◽  
Michael L. Ganz ◽  
Bruce Sill ◽  
Shalini Hede ◽  
...  
Keyword(s):  
United States ◽  
Chronic Hepatitis ◽  
Cost Effectiveness ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
The United States ◽  
Hepatitis C Infection ◽  
Genotype 3

scholarly journals Cost-Effectiveness of Boceprevir in Patients Previously Treated for Chronic Hepatitis C Genotype 1 Infection in the United States

2013 ◽  
Vol 16 (6) ◽  
pp. 973-986 ◽  
Author(s):  
Jagpreet Chhatwal ◽  
Shannon A. Ferrante ◽  
Cliff Brass ◽  
Antoine C. El Khoury ◽  
Margaret Burroughs ◽  
...  
Keyword(s):  
United States ◽  
Chronic Hepatitis ◽  
Cost Effectiveness ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
The United States ◽  
Genotype 1 ◽  
Previously Treated
Sign in / Sign up

Export Citation Format

Share Document